Explore our flagship portfolio of natural protein peptides, biological raw materials, and high-performance nutritional ingredients.
Chickpea protein peptides represent a quantum leap in the plant-based nutrition sector. Obtained through advanced enzymatic hydrolysis of Cicer arietinum protein isolates, these small-molecule peptides (typically <1,000 Daltons) offer exceptional bioavailability compared to intact proteins. The process breaks down complex polypeptide chains into highly active di- and tri-peptides, making absorption almost instantaneous.
At a molecular level, chickpea peptides contain rich profiles of essential amino acids (branched-chain amino acids, BCAA), arginine, glutamic acid, and aspartic acid. This biological configuration supports tissue repair, immunological homeostasis, and metabolic regulation.
Unlocking cost efficiencies and scale capabilities for high-purity bioactive plant proteins from Jiangxi.
Our partner facilities leverage multi-stage enzymatic cleavage systems utilizing food-grade enzymes. This process operates under low-temperature parameters to preserve the functional and structural integrity of the delicate peptide fragments, avoiding denaturation.
China’s vertically integrated agricultural logistics ensure that premium raw chickpeas are processed immediately post-harvest. This translates into high raw material conversion efficiency, reducing cost barriers for global buyers seeking industrial volumes.
Operating within strict Good Manufacturing Practices (GMP) and certified under ISO 22000, HACCP, and Halal/Kosher frameworks. Every batch undergoes rigorous HPLC and molecular weight distribution profiling to maintain absolute consistency.
B2B ingredient procurement demands more than just product availability; it requires complex logistical harmonization, regulatory compliance dossiers, and consistent sensory performance. Our services are explicitly structured to address the operational pain points of multinational food brands, pharmaceutical companies, and functional beverage manufacturers.
Our chickpea protein peptide powder is designed for seamless formulation compatibility: cold-water soluble, heat-stable under pasteurization temperatures, and organoleptically optimized to minimize bitterness.
| Parameters | Standard Specification | Target Market Application |
|---|---|---|
| Protein Content (dry basis) | ≥ 80% - 90% | Protein Fortified Drinks, Sports Mixes |
| Molecular Weight | < 1,000 Daltons (≥ 80%) | Clinical Nutrition, Infant Formula, Cosmetics |
| Solubility Index | ≥ 95% at pH 3.0 - 9.0 | Clear Functional Beverages, Acidic Liquids |
| Heavy Metals | ≤ 10 ppm (strict control) | Pharmaceutical/Nutritional Intermediates |
Removing international barriers through custom compliance, direct regulatory documentation, and local logistics partnerships.
We offer comprehensive documentation including GRAS (Generally Recognized as Safe) self-affirmation data, US FDA Facility Registrations, and non-GMO project verifications. This minimizes import inspection times at US ports of entry.
Fully compliant with European Food Safety Authority (EFSA) regulations for novel food ingredients. Traceability from agricultural source to the final packaging batch is guaranteed under strict EU-monitored guidelines.
Providing fully audited Halal (MUI approved) and Kosher certifications. We supply local linguistic support for labels, safety data sheets (SDS) in multiple languages, and local custom broker coordination.
Jiangxi Serum Pharma Industries Co., Ltd. is a professional supplier of pharmaceutical and nutritional products in China. For nearly 10 years, we have been dedicated to exporting biological products, vaccines, Western medicines, raw materials, intermediates, medical consumables, food additives, and plant extracts, and have accumulated rich industry experience.
Our pharmaceutical products consist of biological products, vaccines, western medicines, raw material, intermediates, medical consumables, with high quality and affordable prices.
View DetailsOur nutritional ingredients cover several categories as plant extracts, plant oils & proteins, probiotics and other specialties, we are committed to exploring more health ingredients to support people’s health.
View DetailsSerum Pharma continuously monitors cutting-edge market trends. We offer specialized customization solutions to meet functional and pharmaceutical requirements.
Tailor-made mixtures of plant peptides, vitamins, and minerals for comprehensive functional ingredient profiles.
Read MoreOptimized stability, taste-masking, and dissolution rates for bioactive molecules using advanced co-crystallization.
Read MoreUtilizing advanced microbes to synthesize active peptides and compounds with high precision and yield.
Read MoreStay updated with our latest industry market research, molecular breakthroughs, and biochemical solutions.
An analysis of the global shift towards plant-derived squalene. Highlighting applications in clean beauty, vaccination adjuvants, and nutritional lipids, signaling the continuous transition away from marine animal sourcing.
Reviewing the therapeutic functions, manufacturing stability protocols, and structural demands of Dexamethasone Sodium Phosphate within emergency and anti-inflammatory clinical setups globally.
Just now, a bombshell emerged in the global weight-loss drug industry: On April 1, 2026, the FDA officially approved Eli Lilly's Foundayo™ (orforglipron) — the world's first and only GLP1 weight-loss drug that can be taken orally at any time of day without dietary restrictions. The approval process took only 50 days from submission, setting a record for the fastest FDA approval. This development has thrust the entire GLP1 pathway, particularly the peptide route, into the spotlight.
Comprehensive technical and logistical answers to facilitate smooth B2B purchasing processes.
Unlike intact plant protein isolates which require extensive gastrointestinal breakdown, chickpea peptides undergo prior controlled enzymatic hydrolysis. This yields low-molecular-weight fractions (primarily below 1,000 Da) that are directly absorbed in the jejunum via specialized peptide transporters. This provides a significantly higher rate of bioavailability, better solubility across a wider pH range, and reduced gastrointestinal discomfort.
Our partner factories in China are designed with fully automated continuous countercurrent extraction tunnels and spray dryers. We operate on a vertical integration model from raw material chickpea cultivation sourcing to final powder purification. This scale enables us to consistently fulfill high-volume contracts (100+ tons per annum) while maintaining absolute batch-to-batch consistency and high molecular purity.
Yes, our manufacturing systems are certified by global auditing bodies. We supply complete dossiers verifying our compliance with non-GMO requirements, allergen-free status (free from gluten, soy, dairy, and animal-derived cross-contaminations), Halal standards (MUI approved), and Kosher regulations.
Every production run is validated using High-Performance Liquid Chromatography (HPLC) to verify molecular weight distribution profiles. We also employ Atomic Absorption Spectroscopy (AAS) to ensure heavy metal parameters (lead, arsenic, mercury, cadmium) are significantly lower than strict international safety limits (e.g. EU & FDA standards).
We maintain dedicated customs brokerage relationships globally, facilitating smooth import-export channels. We provide custom documentation packages including Certificate of Analysis (COA), Safety Data Sheets (SDS), Phytosanitary Certificates, and Country of Origin declarations, matching the local clearance prerequisites of your destination port.
Premium specialized plant proteins, active pharmaceutical ingredients, and stable powders for global health industries.
